About the Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers. Session
Post-treatment monitoring in cancer care is essential for identifying recurrence and managing the long-term health of survivors. After the completion of primary cancer treatment, patients are at risk of both recurrence of the original cancer and the development of secondary cancers. Regular surveillance through imaging tests, blood work, and physical exams helps detect any signs of recurrence early, improving the chances for effective intervention. For some cancers, genetic markers and specific molecular tests are employed to monitor for recurrence or the emergence of treatment-resistant mutations. Additionally, long-term monitoring also includes addressing the psychological and emotional impact of survivorship, as patients may face anxiety about recurrence. The integration of personalized monitoring strategies, based on the type and stage of cancer, offers a more tailored and proactive approach to survivorship care, significantly improving overall outcomes and quality of life for cancer survivors.
Topics Covered in Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers.
Surveillance Imaging
Tumor Marker Testing
Molecular Relapse Detection
Second Malignancy Risk
Follow-Up Schedules
Shared Care Models
Related Scientific Sessions at CIOC 2027
Why Attend the Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers. Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers. work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers. research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers. track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers. Conference 2027 — FAQs
What is the Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers. track at CIOC 2027?
The Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers. track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers.. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers. sessions?
Cancer researchers and clinicians, educators and students with an interest in Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers. are all welcome — whether presenting or attending.
Can I present my research in the Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers. track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers. sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Post-Treatment Monitoring: Surveillance for recurrence and secondary cancers. track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.